Serum Protein and Genetic Tumor Markers of Gastric Carcinoma

  • He, Chao-Zhu (Department of Gastroenterology, the First Affiliated Hospital of Nanchang University / Jiangxi Institute of Gastroenterology and Hepatology) ;
  • Zhang, Kun-He (Department of Gastroenterology, the First Affiliated Hospital of Nanchang University / Jiangxi Institute of Gastroenterology and Hepatology)
  • Published : 2013.06.30


The high incidence of gastric cancer and consequent mortality pose severe threats to human health. Early screening, diagnosis and treatment are the key to improve the prognosis of the patients with gastric cancer. Gastroscopy with biopsy is an efficient method for the diagnosis of early gastric cancer, but the associated discomfort and high cost make it difficult to be a routine method for screening gastric cancer. Serum tumor marker assay is a simple and practical method for detection of gastric cancer, but it is limited by poor sensitivity and specificity. Therefore, people have been looking for novel serum markers of gastric cancer in recent years. Here we review the novel serum tumor markers of gastric cancer and their diagnostic significance, focusing on the discoveries from serum proteomics analyses and epigenetics researches.


  1. Ahn HS, Shin YS, Park PJ, et al (2012). Serum biomarker panels for the diagnosis of gastric adenocarcinoma. Br J Cancer, 106, 733-9.
  2. Cao XY, Jia ZF, Jin MS, et al (2012). Serum pepsinogen II is a better diagnostic marker in gastric cancer. World J Gastroenterol, 18, 7357-61.
  3. Chae H, Lee JH, Lim J (2011). Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis. Korean J Lab Med, 28, 201-6.
  4. Chan DC, Chen CJ, Chu HC, et al (2007). Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann Surg Oncol, 14, 84-93.
  5. Chen SZ (1992). The expression of MG7 corresponding antigen in gastrointestinal polyps and its relation with cancer. Zhonghua Wai Ke Za Zhi, 30, 716-8, 777-8.
  6. Colarossi A, Inga R, Prochazka R, et al (2011). Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population. Rev Gastroenterol Peru, 31, 110-5.
  7. Dilege E, Mihmanli M, Demir U, et al (2010). Prognostic value of preoperative CEA and CA 19-9 levels in resectable gastric cancer. Hepatogastroenterology, 57, 674-7.
  8. Duraker N, Celik AN (2001). The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma, comparison with CEA. J Surg Oncol, 76, 266-71.
  9. Deininger SO, Ebert MP, Fu¨ tterer A, et al (2008) MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. J Proteome Res, 7, 5230-6.
  10. Emoto S, Ishigami H, Yamashita H, et al (2012). Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Gastric Cancer, 15, 154-61.
  11. Fang X, Tie J, Xie Y, et al (2010). Detection of gastric carcinomaassociated antigen MG7-Ag in human sera using surface plasmon resonance sensor. Cancer Epidemiol, 34, 648-51.
  12. Fukuda M, Yokozaki H, Shiba M, et al (2007) Genetic and epigenetic markers to identify high risk patients for multiple early gastric cancers after treatment with endoscopic mucosal resection. J Clin Biochem Nutr, 40, 203-9.
  13. Gomceli I, Bostanci EB, Ozer I, et al (2012). A novel screening biomarker in gastric cancer, serum dickkopf-1. Hepatogastroenterology, 59, 1661-4.
  14. Hong L, Li S, Liu L, et al (2010) The value of MG7-Ag and COX-2 for predicting malignancy in gastric precancerous lesions. Cell Biol Int, 34, 873-6.
  15. Iino C, Shimoyama T, Sasaki Y (2012). Influence of endoscopic submucosal dissection on serum levels of pepsinogens in patients with early gastric cancer. Dig Endosc, 24, 339-42.
  16. Irvani S, Hashemi MR, Moghadam KG, et al (2010). Accuracy of serum pepsinogens I and II, gastrin-17 and anti-helicobacter pylori antibodies in histological diagnoses of atrophic gastritis. Minerva Gastroenterol Dietol, 56, 13-7.
  17. Karpinski P, Myszka A, Ramsey D, et al (2011). Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype. Tumour Biol, 32, 653-9.
  18. Khoder G, Yamaoka Y, Fauche`re JL, et al (2009). Proteomic Helicobacter pylori biomarkers discriminating between duodenal ulcer and gastric cancer. J Chromatogr B Analyt Technol Biomed Life Sci, 877, 1193-9.
  19. Kobayashi Y, Niwa Y, Tajika M, et al (2010). Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer. Hepatogastroenterology, 57, 1631-4.
  20. Liang Y, Pan CQ (2004). The chemical serum protein fingerprint model application in the diagnosis of gastric adenocarcinoma. Lab Med, 27, 122-6
  21. Liu C, Pan C, Shen J, et al (2012). Identification of serum amyloid A in the serum of gastric cancer patients by protein expression profiling. Oncol Lett, 3, 1259-62.
  22. Liu C, Xu L, Han HB, et al (2009). Preliminary study of serum protein fingerprint screening gastric cancer serum markers. Bases Clin Med, 16, 237-40
  23. Liu H, Zhu L, Liu B, et al (2012). Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett, 316, 196-203.
  24. Liu R, Zhang C, Hu Z, et al (2011). A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer, 47, 784-91.
  25. Liu W, Gao X, Cai Q, et al (2010). Identification of novel serum biomarkers for gastric cancer by magnetic bead. Front Biosci (Elite Ed), 2, 961-71.
  26. Li W, Li JF, Qu Y, et al (2008). Comparative proteomics analysis of human gastric cancer. World J Gastroenterol, 14, 5657-64.
  27. Li Y, Yang Y, Lu M, et al (2011). Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Hepatogastroenterology, 58, 2166-70.
  28. Loei H, Tan HT, Lim TK, et al (2012). Mining the gastric cancer secretome, identification of GRN as a potential diagnostic marker for early gastric cancer. J Proteome Res, 11, 1759-72.
  29. Lu HB, Zhao CH, MaYY, et al (2006). The early gastric clinical significance of serum protein fingerprint diagnostic. Progress Mod Biomed, 11, 120-6
  30. Lu HB, Zhou JH, Ma YY, et al (2010). Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Jpn J Clin Oncol, 40, 336-42.
  31. Lu XX, Yu JL, Ying LS, et al (2012). Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Cancer, 118, 5507-17.
  32. Mittal A, Poudel B, Pandeya DR, et al (2012). Serum amyloid a as an independent prognostic factor for renal cell carcinoma--a hospital based study from the Western region of Nepal. Asian Pac J Cancer Prev, 13, 2253-5.
  33. Qi Z. Li JF, Qu Y, et al (2007). Gastric cancer and adjacent tissue associated gene hypermethylation. Shanghai Jiaotong Univ Xue Bao (Medical Sciences), 27, 555-8.
  34. Ren J, Chen Z, Juan SJ, et al (2000). Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique. Cancer, 88, 280-5.<280::AID-CNCR6>3.0.CO;2-7
  35. Rodriguez LG, Guan JL (2005). 14-3-3 regulation of cell spreading and migration requires a functional amphipathic groove. J Cell Physiol, 202, 285-94.
  36. Song J, Bai Z, Han W, et al (2012). Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci, 57, 897-904.
  37. Song MY, Pan KF, Su HJ, et al (2012). Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One, 7, e33608.
  38. Sturgeon CM, Duffy MJ, Hofmann BR, et al (2010). National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem, 56, e1-48.
  39. Tao HQ, He XJ, Ma YY, et al (2011). Evaluation of REG4 for early diagnosis and prognosis of gastric cancer. Hum Pathol, 42, 1401-9.
  40. Tsai KW, Liao YL, Wu CW, et al (2012). Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer, 51, 394-401
  41. Tseng CW, Yang JC, Chen CN, et al (2011). Identification of 14-3-$3\beta$ in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker. Proteomics, 11, 2423-39.
  42. Umemura H, Togawa A, Sogawa K, et al (2011). Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis. J Gastroenterol, 46, 577-85.
  43. Wang B, Zhang Q (2012). The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol, 138, 1659-66.
  44. Wang WJ, Liu CZ, Liu P, et al (2007). SELDI-TOF-MS technology screening gastric cancer serum markers. Environ Occup Med, 24, 143-6.
  45. Wang YS, Shen J, Yu JK, et al (2008). Establish gastric high incidence of gastric cancer serum protein fingerprint diagnostic model. Zhonghua Yu Fang Yi Xue Za Zhi, 24, 677-80
  46. Wang M, Li C, Nie H, et al (2012). Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett, 586, 2382-8.
  47. Wang M, Gu H, Wang S, et al (2012). Circulating miR-17-5p and miR-20a, molecular markers for gastric cancer. Mol Med Report, 5, 1514-20.
  48. Wu C, Luo Z, Chen X, et al (2009). Two-dimensional differential in-gel electrophoresis for identification of gastric cancerspecific protein markers. Oncol Rep, 21, 1429-37.
  49. Wu ZZ, Wang JG, Zhang XL (2009). Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol, 15, 865-70.
  50. Xie X, Ma YT, Yang YN, et al (2010). Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: the Cardiovascular Risk Survey. PLoS One, 5, e13997.
  51. Xue WC, Feng K, Meng DY, et al (2009). Serum protein fingerprint for the early diagnosis of gastric cancer. J Pract Diagn Ther, 18, 153-6.
  52. Yasuda H, Toiyama Y, Ohi M, et al (2011). Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer. J Surg Oncol, 103, 695-9.
  53. Ychou M, Duffour J, Kramar A, et al (2000). Clinical significance and prognostic Value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Disease Markers, 16, 105-10.
  54. Zhang BY, Yuan F, Xiao JC, et al (2010). 14-3-$3\zeta$ protein in gastric carcinoma and its significance. Shanghai Jiaotong Daxue Xue Bao, 30, 1129-32.
  55. Zheng ZG, Xu SH, Xu Q, et al (2010). Use of serum protein profiling for early diagnosis of gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 13, 770-3.
  56. Zheng Z, Li M, Zhang G, et al (2010). Identification of human gastric carcinoma biomarkers by differential protein expression analysis using (18)O labeling and NanoLC-MS/MS coupled with laser capture microdissection. Med Onco, 27, 296-303.
  57. Zheng Y, Cui L, Sun W, et al (2011). MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer Biomark, 10, 71-7.
  58. Zheng Y, Zhang Y, Huang X, et al (2011). Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients. Hepatogastroenterology, 58, 2007-11.
  59. Zou XP, Zhang B, Zhang XQ, et al (2009). Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol. 40, 1534-42.

Cited by

  1. Gastric Cancer in Brunei Darussalam: Epidemiological Trend Over a 27 Year Period (1986-2012) vol.15, pp.17, 2014,
  2. Increased Expression of P2RY2, CD248 and EphB1 in Gastric Cancers from Chilean Patients vol.15, pp.5, 2014,
  3. Role of c-Src activity in the regulation of gastric cancer cell migration vol.32, pp.1, 2014,
  4. Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer vol.35, pp.10, 2014,
  5. Sensitivity of Gastric Cancer Cells to Chemotherapy Drugs in Elderly Patients and Its Correlation with Cyclooxygenase-2 Expression vol.16, pp.8, 2015,
  6. Challenges of deciphering gastric cancer heterogeneity vol.21, pp.37, 2015,